학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 44건 | 목록 1~10
Academic Journal
Journal of Clinical Oncology (J CLIN ONCOL), 10/20/2009; 27(30): e147-9. (1p)
Academic Journal
Lin C; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.; DiCioccio RA; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.; Haykal T; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.; McManigle WC; Division of Pulmonary and Critical Care, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina.; Li Z; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina.; Anand SM; Division of Hematology and Oncology, Department of Medicine, University of Michigan, Ann Arbor, Michigan.; Poe JC; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.; Bracken SJ; Division of Rheumatology and Immunology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.; Jia W; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.; Alyea EP 3rd; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.; Cardones AR; Division of Dermatology, Department of Internal Medicine, University of Kansas Medical Center, Lawrence, Kansas.; Choi T; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.; Gasparetto C; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.; Grunwald MR; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina.; Hennig T; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.; Kang Y; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.; Long GD; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.; Lopez R; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.; Martin M; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.; Minor KK; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.; Quinones VLP; Duke Eye Center, Durham, North Carolina.; Sung AD; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.; Wiggins K; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.; Chao NJ; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.; Horwitz ME; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.; Rizzieri DA; Novant Health Cancer Institute, Charlotte, North Carolina.; Sarantopoulos S; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina. Electronic address: stefanie.sarantopoulos@duke.edu.
Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE
Academic Journal
Whangbo JS; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston MA.; Harvard Medical School, Boston, MA.; Kim HT; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA.; Harvard School of Public Health, Boston, MA.; Mirkovic N; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston MA.; Leonard L; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston MA.; Poryanda S; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston MA.; Silverstein S; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston MA.; Kim S; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston MA.; Reynolds CG; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston MA.; Rai SC; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston MA.; Verrill K; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston MA.; Lee MA; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston MA.; Harvard Medical School, Boston, MA.; Margossian S; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston MA.; Harvard Medical School, Boston, MA.; Duncan C; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston MA.; Harvard Medical School, Boston, MA.; Lehmann L; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston MA.; Harvard Medical School, Boston, MA.; Huang J; Harvard Medical School, Boston, MA.; Dermatology Program, Division of Immunology, Boston Children's Hospital, Boston, MA; and.; Nikiforow S; Harvard Medical School, Boston, MA.; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston MA.; Alyea EP 3rd; Harvard Medical School, Boston, MA.; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston MA.; Armand P; Harvard Medical School, Boston, MA.; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston MA.; Cutler CS; Harvard Medical School, Boston, MA.; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston MA.; Ho VT; Harvard Medical School, Boston, MA.; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston MA.; Blazar BR; Masonic Cancer Center and Division of Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minneapolis, MN.; Antin JH; Harvard Medical School, Boston, MA.; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston MA.; Soiffer RJ; Harvard Medical School, Boston, MA.; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston MA.; Ritz J; Harvard Medical School, Boston, MA.; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston MA.; Koreth J; Harvard Medical School, Boston, MA.; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston MA.
Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Academic Journal
Jan M; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Department of Pathology, Massachusetts General Hospital, Boston, MA.; Leventhal MJ; Broad Institute, Cambridge, MA.; Morgan EA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Wengrod JC; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Nag A; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, MA.; Drinan SD; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, MA.; Wollison BM; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, MA.; Ducar MD; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, MA.; Thorner AR; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, MA.; Leppanen S; Agilent Technologies, Santa Clara, CA.; Baronas J; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Stevens J; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Lane WJ; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Kekre N; Ottawa Blood Disease Centre, The Ottawa Hospital, Ottawa, ON, Canada; and.; Ho VT; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Koreth J; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Cutler CS; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Nikiforow S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Alyea EP 3rd; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Antin JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Soiffer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Ritz J; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Lindsley RC; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Ebert BL; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Academic Journal
Whangbo JS; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA.; Department of Pediatric Oncology and.; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston MA.; Harvard Medical School, Boston, MA.; Kim HT; Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, MA.; Harvard School of Public Health, Boston, MA; and.; Nikiforow S; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston MA.; Harvard Medical School, Boston, MA.; Koreth J; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston MA.; Harvard Medical School, Boston, MA.; Alho AC; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston MA.; Harvard Medical School, Boston, MA.; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.; Falahee B; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston MA.; Harvard Medical School, Boston, MA.; Kim S; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston MA.; Harvard Medical School, Boston, MA.; Dusenbury K; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston MA.; Harvard Medical School, Boston, MA.; Fields MJ; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston MA.; Harvard Medical School, Boston, MA.; Reynolds CG; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston MA.; Harvard Medical School, Boston, MA.; Alyea EP 3rd; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston MA.; Harvard Medical School, Boston, MA.; Armand P; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston MA.; Harvard Medical School, Boston, MA.; Cutler CS; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston MA.; Harvard Medical School, Boston, MA.; Ho VT; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston MA.; Harvard Medical School, Boston, MA.; Antin JH; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston MA.; Harvard Medical School, Boston, MA.; Soiffer RJ; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston MA.; Harvard Medical School, Boston, MA.; Ritz J; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston MA.; Harvard Medical School, Boston, MA.
Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Academic Journal
Nahas MR; Section of Hematological Malignancies and Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, and.; Soiffer RJ; Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and.; Kim HT; Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and.; Alyea EP 3rd; Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and.; Arnason J; Section of Hematological Malignancies and Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, and.; Joyce R; Section of Hematological Malignancies and Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, and.; Antin JH; Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and.; Ho VT; Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and.; Stroopinsky D; Section of Hematological Malignancies and Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, and.; Li S; Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and.; Levine JD; Section of Hematological Malignancies and Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, and.; McMasters M; Section of Hematological Malignancies and Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, and.; Jain S; Section of Hematological Malignancies and Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, and.; Hamdan A; Section of Hematological Malignancies and Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, and.; Tzachanis D; Blood and Marrow Transplant Program, University of California, San Diego, La Jolla, CA.; Bryant MP; Section of Hematological Malignancies and Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, and.; Logan EK; Section of Hematological Malignancies and Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, and.; Bazemore J; Section of Hematological Malignancies and Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, and.; Stewart J; Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and.; Joyce A; Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and.; Stephenson S; Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and.; Washington A; Section of Hematological Malignancies and Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, and.; Cole L; Section of Hematological Malignancies and Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, and.; Pyzer A; Section of Hematological Malignancies and Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, and.; Leaf RK; Section of Hematological Malignancies and Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, and.; Avigan DE; Section of Hematological Malignancies and Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, and.; Rosenblatt J; Section of Hematological Malignancies and Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, and.
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Academic Journal
Patel SS; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Kuo FC; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Gibson CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Steensma DP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Soiffer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Alyea EP 3rd; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Chen YA; Massachusetts General Hospital Cancer Center, Boston, MA.; Fathi AT; Massachusetts General Hospital Cancer Center, Boston, MA.; Graubert TA; Massachusetts General Hospital Cancer Center, Boston, MA.; Brunner AM; Massachusetts General Hospital Cancer Center, Boston, MA.; Wadleigh M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Nardi V; Department of Pathology, Massachusetts General Hospital, Boston, MA; and.; Hasserjian RP; Department of Pathology, Massachusetts General Hospital, Boston, MA; and.; Weinberg OK; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Department of Pathology, Boston Children's Hospital, Boston, MA.
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Academic Journal
Magenau JM; Blood and Marrow Transplantation Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.; Goldstein SC; Blood and Marrow Transplantation Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.; Peltier D; Blood and Marrow Transplantation Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.; Soiffer RJ; Stem Cell/Bone Marrow Transplantation Program, Division of Hematologic Malignancy, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Braun T; Department of Biostatistics, University of Michigan, Ann Arbor, MI.; Pawarode A; Blood and Marrow Transplantation Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.; Riwes MM; Blood and Marrow Transplantation Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.; Kennel M; Blood and Marrow Transplantation Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.; Antin JH; Stem Cell/Bone Marrow Transplantation Program, Division of Hematologic Malignancy, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Cutler CS; Stem Cell/Bone Marrow Transplantation Program, Division of Hematologic Malignancy, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Ho VT; Stem Cell/Bone Marrow Transplantation Program, Division of Hematologic Malignancy, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Alyea EP 3rd; Stem Cell/Bone Marrow Transplantation Program, Division of Hematologic Malignancy, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Parkin BL; Blood and Marrow Transplantation Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.; Yanik GA; Blood and Marrow Transplantation Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.; Choi SW; Blood and Marrow Transplantation Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.; Lewis EC; Department of Clinical Biochemistry and Pharmacology, Ben-Gurion University of the Negev, Beer-Sheva, Israel; and.; Dinarello CA; Department Medicine and Immunology, University of Colorado, Aurora, CO.; Koreth J; Stem Cell/Bone Marrow Transplantation Program, Division of Hematologic Malignancy, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Reddy P; Blood and Marrow Transplantation Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[Author] Alyea EP 3rd
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어